Requesting Insurance Coverage For Ketamine Therapy For Qualifying Patients.
Impact
If passed, SR139 requests that beginning January 1, 2024, Medicaid programs and private insurance policies provide coverage for a percentage of ketamine therapy costs. This could significantly improve access for individuals who have not found relief through conventional antidepressants, thereby enhancing the overall mental health treatment landscape in Hawaii. By formalizing this request, the resolution seeks to align insurance practices with emerging treatment modalities, addressing a critical gap in mental health care.
Summary
Senate Resolution 139 (SR139) aims to request insurance coverage for ketamine therapy for qualifying patients suffering from depression in Hawaii. The resolution highlights the State's responsibility to enhance the health and well-being of its citizens, particularly those with mental health challenges. Citing research that positions ketamine as a viable treatment for treatment-resistant depression, SR139 advocates for the inclusion of this therapy within existing health insurance frameworks in the state.
Contention
Notably, while the resolution presents an innovative approach to addressing mental health challenges, it may also prompt discussions regarding the implications of covering unconventional therapies like ketamine. Concerns may arise regarding cost, effectiveness, and the regulation of such treatments through insurance frameworks. Stakeholders, including healthcare professionals and insurers, may debate the necessity and appropriateness of including ketamine therapy in standard treatment protocols as well as its long-term impact on patients and the healthcare system.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Ketamine Therapy To Treat Depression And Suicide Ideation.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.
Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Step Therapy Requirements For Stage Two Through Stage Five Cancer.